For a Part D rebatable drug (including a biosimilar) that is not a generic drug or a plasma-derived product, in 428.301(b)(2)(ii), CMS proposes an applicable percent reduction of 25 percent for the first applicable period such Part D rebatable drug is currently in shortage, 10 percent for the second applicable period, and 2 percent for each subsequent applicable period
As noted previously, under this scenario, given that there is no additional rebate amount due upon reconciliation compared to the rebate amount stated on the Rebate Report, there would not be a civil money penalty assessed on the reconciled rebate amount
Notably, the risk of ischemic stroke escalated with the number of cigarettes smoked per day, showing a dose-response relationship, but former smoking did not significantly impact stroke risk
Brain development is not complete until the 20s, and nicotine may chemically alter a teens developing brain, making them more susceptible to addiction
Facts & Statistics Smoking The Centers for Disease Control estimated that smoking increases the risk: For coronary heart disease by 2 to 4 times For stroke by 2 to 4 times Of men developing lung cancer by 25 times Of women developing lung cancer by 25.7 times Increase chances of developing other serious heart or lung conditions Smokeless Tobacco Use of smokeless tobacco, like chewing tobacco, can cause many health issues
